Repository

• Home
• Repository
• Publications

Publications

Prognostic Impact of Concomitant Genomic Alterations in FGFR2‐Positive Cholangiocarcinoma Treated With Pemigatinib Liguori C, Giampieri R, Delaunay B, Pinterpe G, Mazzocca A, Hollebecque A, Blanc JF, Bouattour M, Assenat E, Abdelghani MB, Sarabi M, Niger M, Vivaldi C, Mandalà M, Palloni A, Bensi M, Garattini SK, Tougeron D, Combe P, Salati M, Rimini M, Casadei-Gardini A, Cella CA, Tucci M, Diana A, Mori E, Longarini R, Artru P, Roth G, Evesque L, Vienne A, Turpin A, Hiret S, Bourgeois V, Herve C, Paulon R, Stacoffe M, Malka D, Delaye M, Edeline J, Lievre A, Guimbaud R, Balsano R, Fares N, Berardi R, Parisi A. Liver Int. 2026 Aug;46(8):e70813. doi: 10.1111/liv.70813 2026  Result from

Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real-World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab Rimini M, Lamarca A, Ikeda M, Abidoye O, Lucchetti J, Antonuzzo L, Kim JW, Vogel A, Nichetti F, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Peeters F, Braconi C, Pinato DJ, Tamburini E, Pircher C, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Martirena A, Landriscina M, Finkelmeier F, Oneda E, Avallone A, Dell'Aquila E, Perkhofer L, Kim IH, Formica V, de Sousa Pinto CM, Garajova I, Kang B, Corallo S, Fenocchio E, Farinea G, Pastorino A, Diana A, Changhoon Y, Schirripa M, Rodriquenz MG, Scartozzi M, Zumstein L, Ghidini M, Prager GW, Aprile G, Spinelli GP, Yung-Yeh S, Chan SL, Bolnykh I, Lancianese A, Satake T, Bekaii-Saab T, Lavacchi D, Passeri L, Ferrara M, Kang M, Viola MG, Bozzarelli S, Persano M, Masi G, Balsano R, Niger M, Lonardi S, Salani F, Camera S, Ratti F, Fornaro L, Rimassa L, Casadei-Gardini A. Int J Cancer. 2026 Jul 29. doi: 10.1002/ijc.70641. 2026  Result from

Economic Evidence on Biliary Tract Cancer: A Systematic Review Rocha-Gomes J, Teixeira AS, Ruiz-Romeo M, Oliveira JM, Ramos P Cancers (Basel). 2026 Jun 25;18(13):2057. doi: 10.3390/cancers18132057 2026  Result from   OA Funded by

Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma Gonzalez-Sanchez E, Vallette M, Garcia-Collado L, Ravichandra A, Minini M, Pavy A, Amengual J, Roldán-Hernández CA, Ramirez AM, Louis C, Lozano JJ, Fabregat I, Guedj N, Paradis V, Coulouarn C, Aoudjehane L, Fouassier L, Vaquero J Biomed Pharmacother. 2026 Jul 6;201:119741. doi: 10.1016/j.biopha.2026.119741 2026  Result from

Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis Camera S, Vogel A, Rimini M, Ikeda M, Abidoye O, Lucchetti J, Antonuzzo L, Kim JW, Nichetti F, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Peeters F, Braconi C, Pinato DJ, Tamburini E, Pircher C, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Martirena A, Lamarca A, Landriscina M, Finkelmeier F, Oneda E, Avallone A, Dell'Aquila E, Perkhofer L, Kim IH, Formica V, de Sousa Pinto CM, Garajova I, Kang B, Corallo S, Fenocchio E, Farinea G, Pastorino A, Diana A, Changhoon Y, Schirripa M, Rodriquenz MG, Scartozzi M, Zumstein L, Ghidini M, Prager GW, Aprile G, Spinelli GP, Yung-Yeh S, Chan SL, Warmington E, Lancianese A, Satake T, Bekaii-Saab T, Giordano G, Lavacchi D, Passeri L, Ferrara M, Rossari F, Lo Prinzi F, Kang M, Prete AA, Bozzarelli S, Persano M, Masi G, Balsano R, Niger M, Lonardi S, Salani F, Fornaro L, Rimassa L, Casadei-Gardini A. ESMO Open. 2026 Jul 6;11(7):108248. doi: 10.1016/j.esmoop.2026.108248 2026  Result from